CAPRICOR DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

Rosen Law Firm alerts investors in Capricor Therapeutics (CAPR) who purchased securities between December 17, 2025 and July 26, 2026 of an important September 28, 2026 deadline to join a securities class action. The lawsuit alleges that Capricor made materially false statements regarding changes to its statistical analysis plan for Deramiocel without FDA agreement, creating significant regulatory approval risks that were not properly disclosed to investors.